Changes in central adipose tissue after switching to integrase inhibitors
Paula Debroy(The University of Texas Health Science Center at Houston), Jordan E. Lake(The University of Texas Health Science Center at Houston), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), Jovana V. Milić(École Polytechnique Fédérale de Lausanne), Guido Ligabue(University of Modena and Reggio Emilia), Han Feng(Tulane University), Giulia Besutti(University of Modena and Reggio Emilia), Federica Carli, Cristina Mussini(University of Modena and Reggio Emilia), Stefano Draisci(University of Modena and Reggio Emilia), Hongyu Miao(The University of Texas Health Science Center at Houston), Giovanni Guaraldi(University of Modena and Reggio Emilia)
Cited by 19
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424